Hideki Hosono

594 total citations
22 papers, 395 citations indexed

About

Hideki Hosono is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hideki Hosono has authored 22 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Molecular Biology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hideki Hosono's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (11 papers) and HER2/EGFR in Cancer Research (8 papers). Hideki Hosono is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (11 papers) and HER2/EGFR in Cancer Research (8 papers). Hideki Hosono collaborates with scholars based in Japan. Hideki Hosono's co-authors include Teizo Asano, Mika K. Kaneko, Yukinari Kato, Masato Sano, Junko Takei, Takuro Nakamura, Ren Nanamiya, Miyuki Yanaka, Manabu Kawada and Tomokazu Ohishi and has published in prestigious journals such as International Journal of Molecular Medicine, Oncology Reports and Oncology Letters.

In The Last Decade

Hideki Hosono

22 papers receiving 395 citations

Peers

Hideki Hosono

ONCOL

IMMUN

RNMI

PRM

Ren Nanamiya Japan

Wout de Mey Belgium

Yoshikazu Furusawa Japan

Frederike A. Hartl Germany

Ulrike Schoetz Germany

Ian L. Linde United States

Esmeralda Beck-Garcìa Germany

Francesca Avogadri-Connors United States

Tim Fessenden United States

Julia M. Laufer Switzerland

Ren Nanamiya Japan

Hideki Hosono

253 ×0.9

ONCOL

191 ×1.0

IMMUN

94 ×0.8

RNMI

91 ×0.8

32 ×0.8

PRM

Citations per year, relative to Hideki Hosono Hideki Hosono (= 1×) peers Ren Nanamiya

Countries citing papers authored by Hideki Hosono

Since Specialization

Citations

This map shows the geographic impact of Hideki Hosono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Hosono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Hosono more than expected).

Fields of papers citing papers by Hideki Hosono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Hosono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Hosono. The network helps show where Hideki Hosono may publish in the future.

Co-authorship network of co-authors of Hideki Hosono

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Hosono. A scholar is included among the top collaborators of Hideki Hosono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Hosono. Hideki Hosono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Asano, Teizo, Tomokazu Ohishi, Junko Takei, et al.. (2021). An Anti-HER2 Monoclonal Antibody H ₂ Mab-41 Exerts Antitumor Activities in Mouse Xenograft Model Using Dog HER2-Overexpressed Cells. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 184–190. 12 indexed citations

Nanamiya, Ren, Junko Takei, Teizo Asano, et al.. (2021). Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 101–106. 37 indexed citations

Asano, Teizo, Ren Nanamiya, Junko Takei, et al.. (2021). Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 107–112. 37 indexed citations

Hosono, Hideki, Teizo Asano, Junko Takei, et al.. (2021). Development of an Anti-Elephant Podoplanin Monoclonal Antibody PMab-265 for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 141–145. 12 indexed citations

Tanaka, Tomohiro, Teizo Asano, Masato Sano, et al.. (2021). Epitope Mapping of the Anti-California Sea Lion Podoplanin Monoclonal Antibody PMab-269 Using Alanine-Scanning Mutagenesis and ELISA. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 196–200. 6 indexed citations

Nanamiya, Ren, Tomokazu Ohishi, Junko Takei, et al.. (2021). Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG _2a -f Exerts Antitumor Activities in Mouse Xenograft Models of Dog Epidermal Growth Factor Receptor-Overexpressed Cells. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 177–183. 21 indexed citations

Tanaka, Tomohiro, Ren Nanamiya, Junko Takei, et al.. (2021). Development of Anti-Mouse CC Chemokine Receptor 8 Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(2). 65–70. 32 indexed citations

Nanamiya, Ren, Junko Takei, Teizo Asano, et al.. (2021). Ferret Podoplanin Is Detected by PMab-241 in Immunohistochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 134–140. 1 indexed citations

Tanaka, Tomohiro, Teizo Asano, Masato Sano, et al.. (2021). Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 124–133. 25 indexed citations

10.

Nanamiya, Ren, Masato Sano, Teizo Asano, et al.. (2021). Epitope Mapping of an Anti-Human Epidermal Growth Factor Receptor Monoclonal Antibody (EMab-51) Using the RIEDL Insertion for Epitope Mapping Method. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 149–155. 15 indexed citations

11.

Takei, Junko, Teizo Asano, Tomohiro Tanaka, et al.. (2021). Development of a Novel Anti-HER2 Monoclonal Antibody H ₂ Mab-181 for Gastric Cancer. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 168–176. 7 indexed citations

12.

Takei, Junko, Teizo Asano, Ren Nanamiya, et al.. (2021). Development of Anti-human T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(2). 71–75. 15 indexed citations

13.

Asano, Teizo, Tomokazu Ohishi, Junko Takei, et al.. (2021). Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma. Oncology Reports. 46(2). 22 indexed citations

14.

Sayama, Yusuke, Mika K. Kaneko, Junko Takei, et al.. (2021). Establishment of a novel anti-TROP2 monoclonal antibody TrMab-29 for immunohistochemical analysis. Biochemistry and Biophysics Reports. 25. 100902–100902. 20 indexed citations

15.

Tanaka, Tomohiro, Tomokazu Ohishi, Teizo Asano, et al.. (2021). An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models. Oncology Reports. 46(1). 18 indexed citations

16.

Kaneko, Mika K., Tomokazu Ohishi, Takuro Nakamura, et al.. (2020). Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(5). 167–174. 20 indexed citations

17.

Kato, Yukinari, Tomokazu Ohishi, Junko Takei, et al.. (2020). An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H ₂ Mab-19 Exerts Antitumor Activity in Mouse Colon Cancer Xenografts. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(4). 123–128. 9 indexed citations

18.

Kaneko, Mika K., Masato Sano, Junko Takei, et al.. (2020). Development and Characterization of Anti-Sheep Podoplanin Monoclonal Antibodies PMab-253 and PMab-260. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(4). 144–155. 12 indexed citations

19.

Hosono, Hideki, Junko Takei, Tomokazu Ohishi, et al.. (2020). Anti‑EGFR monoclonal antibody 134‑mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma. International Journal of Molecular Medicine. 46(4). 1443–1452. 7 indexed citations

20.

Hosono, Hideki, Tomokazu Ohishi, Junko Takei, et al.. (2020). The anti‑epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab‑16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma. Oncology Letters. 20(6). 1–1. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact